New York, NY, July 26, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Cancer Registry Software Market by Type (Integrated and Standalone), by Database (Public and Commercial), By Delivery (Cloud and On-Premises), By Application (Cancer Reporting, Product Outcome Evaluation, Clinical Studies, Patient Care Management, and Medical Research), and by End-User (Hospitals, Healthcare Providers, Research Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global cancer registry software market was approximately USD 50 million in 2018 and is expected to generate around USD 100 million by 2025, at a CAGR of around 10.32% between 2019 and 2025.

Cancer registry software maintains records of cancer incidences, lists down the causes and current techniques of cancer healthcare that are being performed. It is a repository that contains information on cancer and its various implications. The cancer registry software market globally is growing due to the increasing cancer incidences, improved healthcare facilities, supportive government initiatives, reducing healthcare costs, rising importance of electronic healthcare records, and escalating requirement to use data related to cancer for surveillance. However, data security and issues related to the privacy of data may limit the cancer registry software market globally in the future.

Browse through 88 Tables & 36 Figures spread over 126 Pages and in-depth TOC on “Global Cancer Registry Software Market: By Type, Applications, Industry Size, Share, Trends, Analysis, and Forecast, 2018–2025”.

Request Free Sample Report of Global Cancer Registry Software Market @

The cancer registry software market is divided based on type, database, delivery, application, and end-user. Based on type, the market is divided into integrated and standalone software. The standalone software segment is likely to grow notably in the future, as the software is used by many TPAs and government organizations for registering cancer cases and health management. It is also adaptable and interoperable along with being easy to use. Additionally, it stores and processes registry data and has high flexibility and multiple system use. By database, the market includes commercial and public databases. Based on delivery, the market is categorized into the cloud and on-premises. The application segment comprises cancer reporting, product outcome evaluation, clinical studies, patient care management, and medical research. The end-user segment includes hospitals, healthcare providers, research centers, and others. Research centers generally use this software, as they are responsible for new product development and cancer research using existing patient database.

North America is most the significant contributor to the cancer registry software market share globally, mainly due to the increasing number of hospitals, rising cancer incidences, and growing government initiatives and investments in R&D and IT related to cancer. Additionally, researchers have found rising incidences of triple-negative breast cancer among women in the U.S. There are advancements in processes and their easy implementation, resulting in increased healthcare efficiency. Cloud computing, collaborative tools, and autonomous systems are highly important in this regional market. Technology and internet policy are of primary concern for The Department of Commerce. The American Cancer Society has developed tools to monitor treatment. For example, they have worksheets to track appointments, side-effects, treatment options, surgeries, medicines, supplements, and vitamins, which are shared with doctors and cancer care team.

Request for PDF Brochure of This Report:

The European cancer registry software market holds a major share globally, due to the software’s ease of operability and efficient resource planning and rising government funding. This makes the software feasible for quick and easy implementation of business level software solutions in the healthcare market. Companies like Elekta provide highly precise treatments for cancer radiation and voxel-based tools. There are multiple outbound investments for research and development. The UK, France, and Germany have huge potential to aid various R&D activities in this area. The governments improve collection and transparency of health data and invest wisely. There are many platforms that are increasingly used for cancer research and maintenance of records. “iManageCancer” is one such self-management technology, which has the collaboration of five European countries to create a software platform to manage cancer.

The Asia Pacific region will experience the highest CAGR in the cancer registry software market in the future, owing to the rapidly growing software demand in India and Singapore and enhancements in infrastructure, healthcare facilities, and hospitals. There are various companies providing segment shape optimization, smart sequencing, and tools for data optimization while viewing research data on cancer. The medical service consumers in this market have become more aware of the importance of their healthcare upkeep, which also helps boost the cancer registry management software solutions demand. Many cancer centers are being developed in low- and middle-income countries (LMICs) of Asia for patient management, adequate records development, and update procedures and care plans of patients. This, in turn, helps in understanding the diagnosis, prevention, causes, and treatment of cancer.

Browse the full “Cancer Registry Software Market by Type (Integrated and Standalone), by Database (Public and Commercial), By Delivery (Cloud and On-Premises), By Application (Cancer Reporting, Product Outcome Evaluation, Clinical Studies, Patient Care Management, and Medical Research), and by End-User (Hospitals, Healthcare Providers, Research Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at

The Middle East and Africa is an immature regional market for cancer registry software market, which is projected to grow slowly over the forecast time period. The Latin American cancer registry software market witnessed moderate growth in the past years.

Inquire more about this report before purchase @

Some noticeable players of the global cancer registry software market are McKesson Corporation, Elekta, C/NET Solutions, Electronic Registry Systems, Rocky Mountain Cancer Data Systems, and Onco.

Request customized copy of report @

This report segments the global cancer registry software market into:

Global Cancer Registry Software Market: By Type

  • Integrated Software
  • Standalone Software

Global Cancer Registry Software Market: By Database

  • Public Database
  • Commercial Database

Global Cancer Registry Software Market: By Application

  • Cancer Reporting
  • Product Outcome Evaluation
  • Clinical Studies
  • Patient Care Management
  • Medical Research

Global Cancer Registry Software Market: By Delivery

  • On-Premises
  • Cloud

Global Cancer Registry Software Market: By End-User

  • Hospitals
  • Healthcare Providers
  • Research Centers
  • Others

Global Cancer Registry Software Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn:
Follow Us Twitter:

Visit Our Blog:  | Web Series Reviews

Contact Us:

Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651